HIV-1 immunopathogenesis: How good interferon turns bad
- 31 May 2007
- journal article
- review article
- Published by Elsevier BV in Clinical Immunology
- Vol. 123 (2), 121-128
- https://doi.org/10.1016/j.clim.2006.09.016
Abstract
No abstract availableKeywords
This publication has 72 references indexed in Scilit:
- Differential expression of IFN-α and TRAIL/DR5 in lymphoid tissue of progressor versus nonprogressor HIV-1-infected patientsProceedings of the National Academy of Sciences of the United States of America, 2006
- CD4+ T-cell death induced by infectious and noninfectious HIV-1: role of type 1 interferon-dependent, TRAIL/DR5-mediated apoptosisBlood, 2005
- Peak SIV replication in resting memory CD4+ T cells depletes gut lamina propria CD4+ T cellsNature, 2005
- Mini ReviewHuman Interferons Alpha, Beta and OmegaGrowth Factors, 2004
- Human Immunodeficiency Virus Type 1 Activates Plasmacytoid Dendritic Cells and Concomitantly Induces the Bystander Maturation of Myeloid Dendritic CellsJournal of Virology, 2004
- Interferon-α generation and immune reconstitution during antiretroviral therapy for human immunodeficiency virus infectionAIDS, 2001
- Interleukin-1β Converting Enzyme–like Protease Involvement in Fas-induced and Activation-induced Peripheral Blood T Cell Apoptosis in HIV Infection. TNF-related Apoptosis-inducing Ligand Can Mediate Activation-induced T Cell Death in HIV InfectionThe Journal of Experimental Medicine, 1997
- Phase I Trial of Interferon Alfa-n3 in Early-Stage Human Immunodeficiency Virus Type 1 Disease: Evidence for Drug Safety, Tolerance, and Antiviral ActivityThe Journal of Infectious Diseases, 1996
- Use of recombinant interferon-α in Human Immunodeficiency Virus (HIV)-infected individualsBiotherapy, 1994
- Activation-induced death by apoptosis in CD4+ T cells from human immunodeficiency virus-infected asymptomatic individuals.The Journal of Experimental Medicine, 1992